Safety and Dignity Front and Center: The Opioid Epidemic in the Time of COVID-19 - On Demand Access
-
You must log in to register
- Member - Free!
- Resident Member - Free!
- Allied Staff Member - Free!
- Professional Staff Nonmember - $265
- Other Nonmember - $265
The opioid epidemic continues to take a punishing toll on individuals, families and communities around the country. The COVID-19 pandemic has magnified the opioid epidemic’s impact. In the face of this, oral and maxillofacial surgeons and their teams have adopted safe opioid prescribing practices. The epidemic is evolving and so must the response. This 90-minute webinar will update participants on opioid and other substance use and provide actionable steps to build on safe opioid prescribing with universal screening, reducing stigma and supporting recovery.
This course is included in AAOMS’s current CE online offerings that appear to count toward the eight hours required by the MATE Act to other session descriptions.
Learning Objectives
At the conclusion of this program, participants should be able to:
- Describe the evolution and current epidemiology of the opioid epidemic.
- Apply effective screening strategies for substance use disorder.
- Identify unintentionally stigmatizing policies and practices for change.
- Demonstrate support for recovery from substance use.
An Internet-based CDE/CME Activity
Original Release Date: April 27, 2021
Expiration Date: December 31, 2025
Estimated time to complete this educational activity: 1.5 hours
Method of participation: Self-Study
Melinda Campopiano von Klimo, MD
Melinda Campopiano von Klimo, MD, is board-certified in family medicine with additional credentialing in addiction medicine. She practiced primary care and addiction medicine for 10 years in urban and rural settings, integrating primary care and behavioral health. She has led a family medical practice, served as Medical Director of opioid treatment programs (OTPs) and treated patients with buprenorphine in an office-based setting. As a Medical Officer at Substance Abuse and Mental Health Services Administration (SAMHSA) for five years, Dr. Campopiano had regulatory authority for OTPs, updated the federal guidelines for OTPs and wrote new regulations expanding access to buprenorphine. As Senior Medical Advisor at JBS International, she applies clinical experiences and policy and implementation expertise across projects for federal agencies (such as the Health Resources and Services Administration, National Institute on Drug Abuse, SAMHSA, Administration for Children and Families and Department of Justice), states and other organizations (such as the American Society of Addiction Medicine and American Academy of Pediatrics).
Relevant Conflict of Interest Disclosure: No Relevant Conflict of Interest Disclosures were reported.
Continuing Education Provider Approval
The American Association of Oral and Maxillofacial Surgeons is an ADA CERP Recognized Provider.
ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education.
ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry.
The American Association of Oral and Maxillofacial Surgeons designates this activity for 1.5 continuing education credit(s).
AGD - Accepted Program Provider
FAGD/MAGD Credit
11/1/22-12/31/26
Provider ID# 214680
The American Association of Oral and Maxillofacial Surgeons (AAOMS) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American Association of Oral and Maxillofacial Surgeons designates this internet-based enduring material for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Key:
Complete
Next
Failed
Available
Locked